+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2026-2032- Product Image
Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2026-2032- Product Image
Sale

Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126389
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Inhalation Sevoflurane Anaesthetic Agent Market is projected to reach USD 1.18 Billion in 2026. It is expected to continue growing at a CAGR of 10.76%, reaching USD 2.20 Billion by 2032.

Sevoflurane’s Role in Modern Inhalation Anaesthesia

Inhalation sevoflurane anaesthetic agent is a volatile halogenated anaesthetic used to induce and maintain general anaesthesia, particularly when rapid adjustment of anaesthetic depth and prompt recovery are clinically valuable. Its low blood-gas solubility supports relatively fast changes in anaesthetic concentration, while its non-pungent profile can support inhalational induction in selected patients. Clinical use remains dependent on authorised indications, institutional protocols, trained anaesthesia professionals, vapouriser availability, and appropriate monitoring.

Clinical Practice Is Shifting Toward Efficiency, Safety, and Lower Waste

The landscape is being reshaped by ambulatory surgery, enhanced-recovery pathways, tighter perioperative monitoring, and greater attention to operating-room efficiency. These shifts favour agents and delivery systems that permit controllable anaesthetic depth and predictable emergence, while also increasing scrutiny of occupational exposure, scavenging performance, greenhouse-gas emissions, and waste management. Procurement decisions increasingly consider total workflow requirements rather than the medicine alone, including vapouriser compatibility, supply continuity, handling procedures, and staff training.

Artificial Intelligence Supports Monitoring, Planning, and Stewardship

Artificial intelligence can influence sevoflurane use through decision-support tools that analyse physiological signals, estimate anaesthetic depth, identify patterns associated with delayed emergence, and assist closed-loop or semi-automated delivery research. It may also support operating-room scheduling, inventory management, adverse-event surveillance, and environmental reporting. These applications require clinically validated models, transparent human oversight, cybersecurity controls, representative data, and clear accountability; AI should complement, not replace, anaesthesiologist judgment or established monitoring standards.

Regional Dynamics Reflect Different Surgical Systems and Regulatory Priorities

North America combines advanced perioperative infrastructure with strong emphasis on patient safety, environmental stewardship, and supply resilience. Europe places substantial weight on evidence-based prescribing, pharmaceutical regulation, emissions reduction, and coordinated healthcare standards. Asia-Pacific includes highly developed surgical systems alongside rapidly expanding hospital capacity, creating varied requirements for training, procurement, and equipment compatibility. Latin America is influenced by public-private healthcare differences, import dependence, and uneven access to specialised anaesthesia services. The Middle East is investing in tertiary hospitals and surgical capability, while procurement and regulatory pathways vary across states. Africa presents diverse needs shaped by infrastructure, workforce availability, essential-medicine access, and the reliability of oxygen, power, monitoring, and scavenging systems.

Economic and Institutional Groups Have Distinct Procurement Contexts

ASEAN markets are connected by regional trade and healthcare-development priorities but retain distinct regulatory and hospital-capacity profiles. BRICS members span major manufacturing, population, and healthcare systems with differing approaches to domestic production, procurement, and regulatory review. The European Union benefits from shared regulatory structures while national reimbursement and hospital purchasing practices remain important. G7 countries generally have mature surgical infrastructure, robust pharmacovigilance, and heightened attention to sustainability and resilience. GCC states are strengthening advanced hospital capacity and cross-border clinical capability. NATO members represent a diverse set of health systems, but continuity planning, emergency preparedness, and interoperability can influence institutional procurement.

Country Contexts Differ in Regulation, Capacity, and Clinical Adoption

Australia and Canada have established hospital systems and regulated medicine pathways, with procurement shaped by public-sector purchasing, rural access, and sustainability considerations. Brazil, Mexico, India, Russia, and China combine large and varied healthcare environments in which domestic manufacturing, import procedures, regional disparities, and hospital-level resources can affect availability. France, Germany, Italy, Spain, and the United Kingdom operate within mature European regulatory and clinical frameworks, while reimbursement, tendering, and environmental policies differ nationally. Japan and South Korea have sophisticated surgical infrastructure, strong quality requirements, and ageing-population considerations. The United States has extensive procedural capacity and rigorous monitoring expectations, with purchasing influenced by hospital formularies, supply continuity, and perioperative efficiency.

Leaders Should Link Clinical Value With Resilient and Responsible Delivery

Industry leaders should maintain validated quality systems, diversify critical inputs where feasible, and map regulatory requirements across target jurisdictions. They should support hospitals with vapouriser compatibility guidance, safe-storage procedures, scavenging and exposure-control education, and training for effective use in both conventional and ambulatory settings. Environmental priorities should include accurate measurement of volatile-agent use, lower-waste operating practices, and transparent stewardship claims. Organisations evaluating AI should begin with narrowly defined, clinically supervised use cases and require validation, auditability, cybersecurity, and post-deployment monitoring. Partnerships with clinicians, procurement teams, regulators, and sustainability officers can improve adoption while preserving patient safety.

Methodology Combines Regulatory, Clinical, and Health-System Evidence

This executive summary uses a structured review framework focused on the clinical role, delivery requirements, regulatory context, healthcare-system conditions, sustainability considerations, and emerging technology relevant to inhalation sevoflurane anaesthetic agent. Geographic and group-level interpretation is based on differences in surgical capacity, medicine regulation, procurement structures, workforce, infrastructure, and environmental policy. AI implications are assessed as operational and clinical use cases rather than as evidence of established universal practice. Claims are limited to broadly documented characteristics and avoid market estimates, market shares, forecasts, and company-specific assertions.

Sevoflurane’s Future Depends on Safe Use, System Readiness, and Stewardship

Sevoflurane remains relevant where clinicians require a controllable volatile anaesthetic within appropriately monitored general-anaesthesia practice. Its position is shaped not only by pharmacologic characteristics but also by operating-room infrastructure, regulatory oversight, procurement resilience, workforce capability, and environmental expectations. The strongest strategies will combine reliable supply and quality with practical clinical education, responsible emissions management, and carefully governed digital innovation. Regional and country differences make adaptable implementation essential, while patient safety and professional judgment remain the central decision criteria.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Inhalation Sevoflurane Anaesthetic Agent Market, by Delivery Mode
7.1. Introduction
7.2. Handheld Vaporizer
7.3. Machine Vaporizer
7.4. Portable Inhaler
8. Inhalation Sevoflurane Anaesthetic Agent Market, by Patient Age Group
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatric
9. Inhalation Sevoflurane Anaesthetic Agent Market, by Formulation
9.1. Introduction
9.2. Liquid Concentrate
9.3. Pre Valved Cartridges
9.4. Ready To Use Solutions
10. Inhalation Sevoflurane Anaesthetic Agent Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.3.1. Human Clinics
10.3.2. Veterinary Clinics
10.4. Hospitals
10.4.1. Private
10.4.2. Public
11. Inhalation Sevoflurane Anaesthetic Agent Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Inhalation Sevoflurane Anaesthetic Agent Market, by Application
12.1. Introduction
12.2. Cardiac Surgery
12.3. General Surgery
12.3.1. Abdominal
12.3.2. Ent
12.3.3. Orthopedic
12.4. Neurological Surgery
12.5. Obstetrics And Gynecology
12.6. Pediatric Surgery
13. Inhalation Sevoflurane Anaesthetic Agent Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Inhalation Sevoflurane Anaesthetic Agent Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Inhalation Sevoflurane Anaesthetic Agent Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 3S Corporation
17.2. AbbVie Inc.
17.3. Aetos Pharma Private Limited
17.4. Baxter International Inc.
17.5. Cadila Healthcare Ltd.
17.6. Central Glass Co., Ltd.
17.7. Fresenius Kabi AG
17.8. Halocarbon Products Corporation
17.9. Hikma Pharmaceuticals PLC
17.10. Jiangsu Hengrui Medicine Co., Ltd.
17.11. Lunan Pharmaceutical Group Co., Ltd.
17.12. Neon Laboratories Pvt. Ltd.
17.13. Novartis AG
17.14. Novartis India Limited
17.15. Ocean Pharmaceutical Ltd.
17.16. Piramal Enterprises Ltd.
17.17. Raman & Weil Private Limited
17.18. Salvavidas Pharmaceutical Pvt. Ltd.
17.19. Sandoz Group AG
17.20. Troikaa Pharmaceuticals Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Inhalation Sevoflurane Anaesthetic Agent Market, Years Considered for the Study
FIGURE 2. Global Inhalation Sevoflurane Anaesthetic Agent Market, Research Design
FIGURE 3. Global Inhalation Sevoflurane Anaesthetic Agent Market, Research Framework
FIGURE 4. Global Inhalation Sevoflurane Anaesthetic Agent Market, Data Triangulation
FIGURE 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2025 vs 2032 (%)
FIGURE 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 11. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Inhalation Sevoflurane Anaesthetic Agent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Segmentation & Coverage
TABLE 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 4. Global Handheld Vaporizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Handheld Vaporizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Handheld Vaporizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Machine Vaporizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Machine Vaporizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Machine Vaporizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Portable Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Portable Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Portable Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 14. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 24. Global Liquid Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Liquid Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Liquid Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Pre Valved Cartridges Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Pre Valved Cartridges Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Pre Valved Cartridges Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Ready To Use Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ready To Use Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ready To Use Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 34. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Human Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Human Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Human Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Private Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Private Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Private Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Global Cardiac Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Cardiac Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Cardiac Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Abdominal Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Abdominal Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Abdominal Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Ent Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Ent Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Ent Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Orthopedic Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Orthopedic Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Orthopedic Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Neurological Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Neurological Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Neurological Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Obstetrics And Gynecology Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Obstetrics And Gynecology Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Obstetrics And Gynecology Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Pediatric Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Pediatric Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Pediatric Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 98. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 100. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 101. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 102. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 104. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 105. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. North America Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 108. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 110. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 111. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 112. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 114. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 115. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 118. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 120. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 121. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 122. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 124. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 128. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 130. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 131. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 132. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 134. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Middle East Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 138. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 140. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 141. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 142. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 144. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 145. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Africa Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 148. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 151. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 152. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 153. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 155. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 156. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. ASEAN Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 159. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 161. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 162. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 163. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 165. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. GCC Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 169. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 171. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 172. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 173. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 175. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 176. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. European Union Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 179. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 181. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 182. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 183. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 185. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 186. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. BRICS Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 189. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 191. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 192. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 193. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 195. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. G7 Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 199. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 201. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 202. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 203. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 205. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 206. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. NATO Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 209. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 211. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 212. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 213. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 214. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 216. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. United States Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 220. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 221. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 222. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 223. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 224. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 226. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 227. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 230. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 231. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 232. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 233. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 236. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 237. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 240. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 241. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 242. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 243. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 244. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 246. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 247. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 250. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 251. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 252. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 253. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 254. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 256. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 257. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 260. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 261. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 262. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 263. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 264. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 266. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 267. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 270. France Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 271. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 272. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 273. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 274. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 276. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 277. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. France Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 280. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 281. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 282. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 283. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 284. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 286. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 287. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Russia Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 290. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 291. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 292. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 293. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 294. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 296. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 297. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 300. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 301. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 302. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 303. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 304. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 306. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 307. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 308. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 310. China Inhalation Sevoflurane Anaesthetic Agent Market Size, 2017-2032 (USD Million)
TABLE 311. China Inhalation Sevoflurane Anaesthetic Agent Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 312. China Inhalation Sevoflurane Anaesthetic Agent Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 313. China Inhalation Sevoflurane Anaesth

Companies Mentioned

  • 3S Corporation
  • AbbVie Inc.
  • Aetos Pharma Private Limited
  • Baxter International Inc.
  • Cadila Healthcare Ltd.
  • Central Glass Co., Ltd.
  • Fresenius Kabi AG
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lunan Pharmaceutical Group Co., Ltd.
  • Neon Laboratories Pvt. Ltd.
  • Novartis AG
  • Novartis India Limited
  • Ocean Pharmaceutical Ltd.
  • Piramal Enterprises Ltd.
  • Raman & Weil Private Limited
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Sandoz Group AG
  • Troikaa Pharmaceuticals Ltd.

Related Topics

Related Reports

Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032 - Product Image

Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Medical Sevoflurane Market - Global Forecast 2026-2032 - Product Image

Medical Sevoflurane Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Inhalation Anesthetics Market Outlook 2026-2034: Market Share, and Growth Analysis by Type (Desflurane, Sevoflurane, Isoflurane, Other Types), End User - Product Image

Inhalation Anesthetics Market Outlook 2026-2034: Market Share, and Growth Analysis by Type (Desflurane, Sevoflurane, Isoflurane, Other Types), End User

  • Report
  • 160 Pages
  • Global
From
Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 160 Pages
  • Global
From
Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.